The US pathogen reduction system market is expanding as blood banks and healthcare providers increasingly prioritize the safety of blood components and transfusion practices. Growing concerns regarding transfusion-transmitted infections, along with increasing adoption of technologies designed to reduce pathogens in plasma, platelets, and other blood products, are supporting market demand. Continued advancements in pathogen inactivation technologies and investments in blood safety infrastructure are expected to create further opportunities in the US.

The Pathogen Reduction System market size is expected to reach US$ 4.26 Billion by 2034 from US$ 1.63 Billion in 2025. The market is anticipated to register a CAGR of 11.26% during the forecast period 2026–2034.

Growing Focus on Blood Safety

The increasing emphasis on blood safety is a major factor driving the adoption of pathogen reduction technologies. Blood and blood components can potentially carry infectious agents, creating a need for technologies that can complement existing screening and safety procedures. Pathogen reduction systems provide an additional approach for reducing the risk associated with transfusion-transmitted infections.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00015233

Blood centers and healthcare organizations are increasingly evaluating technologies that can improve the safety of blood components while supporting efficient processing workflows. This focus is creating opportunities for manufacturers developing pathogen reduction platforms for different blood components.

Increasing Need for Transfusion Safety

The growing demand for blood transfusions across healthcare settings is supporting the need for advanced blood-processing technologies. Blood components are used in a wide range of medical procedures, including surgeries, trauma care, cancer treatment, and other clinical applications. Maintaining the safety and quality of these components is therefore an important healthcare priority.

Pathogen reduction technologies can help address potential infectious risks by targeting pathogens in blood components. Their role as part of broader transfusion safety strategies is expected to contribute to market expansion as healthcare providers seek additional measures to protect patients.

Technological Advancements in Pathogen Reduction

Technology development is an important component of the pathogen reduction system market. Manufacturers are focusing on improving the efficiency and applicability of pathogen reduction processes while supporting the quality and usability of treated blood components.

Advancements in pathogen inactivation technologies can expand their potential applications across blood-processing operations. Improved systems may also help healthcare facilities integrate pathogen reduction into existing workflows. Continued innovation in treatment processes and system design is expected to create opportunities for market participants.

Application Across Blood Components

Pathogen reduction systems are used in blood-component processing, with technologies designed to address the specific characteristics of different components. Platelets and plasma are important areas of application because they are widely used in transfusion medicine and require appropriate safety measures.

The development of technologies suitable for different blood components can expand the addressable market. As blood centers seek comprehensive approaches to transfusion safety, demand for systems capable of supporting multiple processing requirements may increase.

Role of Blood Centers and Healthcare Facilities

Blood centers represent an important end-user segment because they collect, process, and distribute blood components for transfusion. The integration of pathogen reduction systems into blood-processing operations can provide an additional layer of safety before components are supplied to healthcare facilities.

Hospitals and other healthcare organizations also have an important role in transfusion safety. Increasing awareness of infectious risks and the importance of maintaining high-quality blood components can encourage healthcare providers to adopt advanced technologies and collaborate with specialized blood-processing facilities.

Regional Market Perspective

The pathogen reduction system market is influenced by blood safety regulations, healthcare infrastructure, transfusion practices, technological adoption, and awareness of transfusion-transmitted infections. North America represents an important market due to established blood-processing infrastructure, advanced healthcare systems, and strong emphasis on transfusion safety.

Europe also provides opportunities supported by developed blood donation and transfusion networks and increasing attention to blood-component safety. Asia-Pacific presents significant growth opportunities as healthcare infrastructure expands and blood-processing capabilities improve. Increasing awareness of transfusion safety in emerging healthcare markets may further contribute to adoption.

Competitive Landscape

The market includes specialized medical technology and blood-processing companies developing pathogen reduction and transfusion safety solutions. Key players include:

• TERUMO BCT, INC.
• Cerus Corporation
• Macopharma
• Octapharma
• AngioDynamics, Inc.

These companies compete through technological innovation, product development, blood-processing solutions, and expansion of their healthcare portfolios. Product performance, compatibility with blood-processing workflows, and the ability to address evolving transfusion safety requirements remain important competitive considerations.

Key Market Trends and Opportunities

One of the major trends in the pathogen reduction system market is the increasing focus on proactive approaches to blood safety. Traditional donor screening and laboratory testing remain important, while pathogen reduction can provide an additional approach for addressing infectious risks in blood components.

Another important opportunity is the expansion of blood-processing infrastructure in emerging markets. As healthcare systems improve their capacity for blood collection, testing, storage, and transfusion, demand for technologies that support component safety may increase.

The development of efficient and scalable pathogen reduction processes can also support market expansion. Healthcare providers and blood centers increasingly seek solutions that can be integrated into existing operations without creating unnecessary complexity. Technologies that combine safety benefits with operational efficiency may gain greater adoption.

Future Outlook

The future outlook for the pathogen reduction system market remains strong, supported by increasing attention to transfusion safety, growing demand for blood components, and continued technological development. The market is projected to increase from US$ 1.63 billion in 2025 to US$ 4.26 billion by 2034, reflecting an 11.26% CAGR during 2026–2034.

Continued innovation in pathogen inactivation technologies is expected to influence future market development. Expansion of blood-processing infrastructure, particularly across emerging economies, may create additional opportunities for manufacturers. Increasing efforts to strengthen transfusion safety and reduce infectious risks are likely to encourage healthcare organizations and blood centers to evaluate advanced pathogen reduction solutions through 2034.

Related Reports @

Blood Bank Market Regional Share, Size, Trends, and Forecast by 2031

Blood Banking Devices Market Statistics, Trends, Size, Share, Analysis, Key Players by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish